Clinical Trial Update: Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD) [Phase 1]

View source ↗

Summary

An update on a Phase 1 trial evaluating mesenchymal stromal cells for the treatment of graft-versus-host disease; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Ettore Biagi, MD | Conditions: Graft vs Host Disease | Phase 1 | Status: UNKNOWN